2026-08-13 Drugs SFDA Strengthens Its Global Leadership in Drug Regulation with Launch of NADR Program for Rare Disease Drug Development
2026-08-11 Drugs SFDA Becomes First Regulatory Authority Globally to Approve the Registration of 'ZENBEXUS' for the Treatment of Multiple Myeloma in Adults